Koyfin Home > Directory > Health Care > Inovio Pharma > Return on Capital %

Inovio Pharma Return on Capital % Chart (INO)

Inovio Pharma annual/quarterly Return on Capital % from 2010 to 2020.
  • Inovio Pharma Return on Capital % for the quarter ending June 06, 2020 was -28.92 a -38.52% increase of 11.14 year over year
  • Inovio Pharma Return on Capital % for the last 12 months ending June 06, 2020 was -32.23 a -79.89% increase of 25.75 year over year
  • Inovio Pharma Annual Return on Capital % for 2019 was -71.12 a 27.95% decrease of -19.88 from 2018
  • Inovio Pharma Annual Return on Capital % for 2018 was -51.24 a 22.34% decrease of -11.45 from 2017
  • Inovio Pharma Annual Return on Capital % for 2017 was -39.80 a 18.95% decrease of -7.54 from 2016
Other Margins & Efficiency Metrics:
  • Inovio Pharma EBITDA Margin for the quarter ending June 06, 2018 was $-16m a -1,153.83% increase of 186m year over year
  • Inovio Pharma Return on Equity % for the quarter ending December 12, 2018 was -138.25 a 26.75% decrease of -36.99 year over year
View Chart On Koyfin

Quarterly INO Return on Capital % Data

06/2020-28.92
03/2020-32.24
12/2019-65.57
09/2019-40.05
06/2019-45.77
03/2019-56.52
12/2018-77.33
09/2018-61.90
06/2018-11.58
03/2018-64.06

Annual INO Return on Capital % Data

2019-71.12
2018-51.24
2017-39.80
2016-32.26
2015-15.34
2014-30.02
2013-30.69
2012-37.24
2011-29.26
2010-19.95